Regeneron Pharmaceuticals (REGN)

Income Before Tax

$1.53B

Quarterly · Period ending: · USD

REGN logo

REGN Income Before Tax

Latest reported$1.53B
REGN Quarterly Pre-Tax Income ($0.00 → $1.53B)
High-resolution chart · PNG

REGN income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-14,791,000
-10,218,000
-16,602,000
-3,151,000
-2,844,000
-7,254,000
-700,000
-4,900,000
-7,700,000
-8,800,000
-5,500,000
-1,300,000
2,200,000
-3,800,000
1,200,000
-1,000,000
-4,200,000
-5,800,000
-4,500,000
-4,400,000
-3,700,000
-7,500,000
-2,700,000
-2,400,000
-1,200,000
-2,100,000
0
0
0
0
0
0
-9,100,000
0
0
0
0
0
-2,100,000
-700,000
-500,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.